Why Did The Alaunos Therapeutics (TCRT) Stock Surged In The Extended Session?
Alaunos Therapeutics Inc. (Nasdaq: TCRT) saw a 5.28% increase in its share price to $0.73 during after-hours trading. The clinical-stage cell therapy company, which focuses on oncology, announced its targeted landmarks and priorities for tactical advancement which drove its share price up. What has TCRT shared? Last month, Alaunos Therapeutics (TCRT) announced its key objectives […]